A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1).
暂无分享，去创建一个
F. Khuri | R. Salgia | G. Shapiro | E. Felip | S. Ramalingam | T. Ciuleanu | R. Rosell | J. Spicer | V. Hirsh | I. Bondarenko | B. Zaric | G. Schmid‐Bindert | V. Vukovic | T. Wehler | M. Samaržija | D. Fennell | G. Goss | Z. Andrić | D. Komov | T. Cerić | E. Sheldon | F. Teofilovici | B. Zarić